5,996
likes
2,969
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
Vaccines, excellent real world data Analytics Table
Income Estimates for Vaccines, excellent real world data
Based on this YouTube video's total view count of 158K views and industry-standard rates, the estimated total earning is $111 - $317 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Vaccines, excellent real world data
Explore Vaccines, excellent real world data with 158,459 views, 5,996 likes, and 2,969 comments. Experience the impact of this video content that has captured audience attention.
Pfizer-BioNTech vaccine provides high levels of protection from the first dose https://www.gov.uk/government/news/first-real-world-uk-data-shows-pfizer-biontech-vaccine-provides-high-levels-of-protection-from-the-first-dose https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3790399 BNT162b2 mRNA Vaccine effectiveness in healthcare worker Prospective cohort study of staff undergoing regular asymptomatic testing. The SIREN study N = 29,378 2 weekly intervals Records symptoms, PCR and antibody test results Therefore symptomatic and asymptomatic infections Hazard ratios to compare time Infection in unvaccinated and vaccinated groups Findings, 5th February 2021 People who were antibody negative on recruitment A single dose of BNT162b2 vaccine, effectiveness of 72% 21 days after first dose Rising to 86% seven days after two doses Conclusion Vaccine effectively prevents both symptomatic and asymptomatic infection in working age adults Cohort was vaccinated when the dominant variant in circulation was B1.1.7 Consistent data Israel, Norwich Medical School Pfizer COVID-19 BNT162b2 vaccine, after a single dose, ‘real-world’ At day 21 Vaccine effectiveness, 91% After day 21 Remained at 90% Expected to last form 9 weeks to 6 months Vaccine effectiveness seems to be better at reducing severe disease that at reducing mild disease Public health Scotland Fourth week after first dose, reduced risk of hospitalisation Pfizer, down 84% (n = 650,000) Oxford-AstraZeneca, down 94% (n = 490,000) Combined reduction in over 80s Vaccination associated with 81% reduction in hospitalisation risk in the fourth week
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

